The EVAR Center

Filter Your Results

 

News

 

Zenith p-Branch Device Demonstrates Technical Success and Safety in Feasibility Study

November 26, 2019 -- Findings from a feasibility study of the Zenith p-Branch device (Cook Medical) for treating patients with asymptomatic juxtarenal or pararenal abdominal a…

Medtronic Presents 1-Year Valiant Navion and 4-Year ANCHOR Registry Outcomes

November 22, 2019 -- Medtronic announced the presentation of 1-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and 4-…

Terumo Acquires Aortica Corporation to Further Bolster Its Vascular Graft Portfolio

November 20, 2019 -- Terumo Corporation announced the acquisition of Aortica Corporation, which developed the AortaFit automated case planning software to match fenestrations …

TiGER Registry Commences to Evaluate Terumo Aortic’s Portfolio of Thoracic and Abdominal EVAR Devices

November 18, 2019 -- Terumo Aortic announced the launch of the company’s global endovascular registry know as TiGER (Terumo Aortic Global Endovascular Registry). The stu…

Centerline Biomedical Launches IOPS Intraoperative Positioning System

November 18, 2019 -- Centerline Biomedical, Inc., a spinout company from Cleveland Clinic, announced the successful first-in-human clinical use of the company’s IOPS int…

Analysis From Vascular Quality Initiative Shows Correlation of AAA Size and Outcomes After EVAR

November 6, 2019 -- The Society for Vascular Surgery announced the publication of findings from a study based on 22,975 patient records in the Vascular Quality Initiative (VQI…

Endologix Responds to FDA Safety Communication on Risk of Type III Endoleaks in AFX EVAR Grafts

October 28, 2019 -- The FDA announced that it is evaluating new information on the risk of type III endoleak with the AFX endovascular grafts (AFX with Strata, AFX with Durapl…

Medtronic Gains FDA Breakthrough Device Designations for Valiant TAAA and Valiant Navion LSA Systems

October 8, 2019 -- Medtronic announced the receipt of FDA Breakthrough Device designations for the company’s Valiant thoracoabdominal aortic aneurysm (TAAA) stent graft …

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.